BLT 0.00% 2.6¢ benitec biopharma limited

Ann: QUARTERLY REPORT CONFERENCE CALL TRANSCRIPT-BLT.AX, page-2

  1. 2,524 Posts.
    lightbulb Created with Sketch. 69
    Despite the lack of a current CEO, they at least managed to expound more on limiting paychecks to the most critical. Perhaps that is why there is more cash than previously thought would be at this time.
    They also made more specific comments to outside pharma and made more slightly transparent comments about that relationship. Additionally, it was good to see good effort put into AMD.
    If the cash continues to remain conservatively spent on the science, and an eventual CEO is hired, and a partnership ensues... They will have gone a long way in restoring my faith, and my desire to jump back in fully. I will slowly add to my position, but cautiously. But for now, they better be prepared for shareholder showdown. There will be some hard pressed questions that I hope get asked and answered.

    Good luck from the not so frozen north at the moment! -Peace.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.